WS Data Solutions
Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Neutral
Debt to Equity Rating
Sell
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Neutral
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
Nuvation Bio Inc. (NUVB)
Pharmaceutical Preparations
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
357 TEHAMA STREET, FLOOR 3
SAN FRANCISCO, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
02/10/2021
Market Cap
677,634,377
Shares Outstanding
218,940,000
Weighted SO
218,944,053
Total Employees
N/A
Upcoming Earnings
08/01/2024
Similar Tickers
Beta
1.4010
Last Div
0.0000
Range
0.95-4.16
Chg
-0.0203
Avg Vol
1665738
Mkt Cap
677634377
Exch
NYSE
Country
US
Phone
332 208 6102
DCF Diff
2.5585
DCF
0.1765
Div Yield
0.0000
P/S
398.8431
EV Multiple
-8.2808
P/FV
2.5975
Div Yield %
0.0000
P/E
-1.3081
PEG
-0.0894
Payout
0.0000
Current Ratio
11.4918
Quick Ratio
11.4918
Cash Ratio
0.6710
DSO
861.9068
DIO
0.0002
Op Cycle
861.9070
DPO
1081.3047
CCC
-219.3977
Gross Margin
-0.0353
Op Margin
-66.3237
Pretax Margin
-300.6004
Net Margin
-300.6004
Eff Tax Rate
-0.0206
ROA
-0.8586
ROE
-0.9879
ROCE
-0.2073
NI/EBT
1.0000
EBT/EBIT
4.5323
EBIT/Rev
-66.3237
Debt Ratio
0.4853
D/E
1.1223
LT Debt/Cap
0.5167
Total Debt/Cap
0.5288
Int Coverage
-24.1656
CF/Debt
-0.2917
Equity Multi
2.3126
Rec Turnover
0.4235
Pay Turnover
0.3376
Inv Turnover
999999.9999
FA Turnover
0.4891
Asset Turnover
0.0029
OCF/Share
-0.3441
FCF/Share
-0.3443
Cash/Share
2.3583
OCF/Sales
-49.5644
FCF/OCF
1.0007
CF Coverage
-0.2917
ST Coverage
-6.1422
CapEx Coverage
-1358.2258
Div&CapEx Cov
-1358.2258
P/BV
2.5975
P/B
2.5975
P/S
398.8431
P/E
-1.3081
P/FCF
-8.0410
P/OCF
-7.9333
P/CF
-7.9333
PEG
-0.0894
P/S
398.8431
EV Multiple
-8.2808
P/FV
2.5975
DPS
0.0000
Latest Headlines (EST)
No Headlines Found